The LCRF Pilot Grant Program supports high-risk, high-reward research projects investigating a wide variety of topics related to lung cancer. Eligible areas of research include but are not limited to:
- Improving our understanding of lung cancer biology
- Prevention and screening for early detection
- Identification of new biomarkers and the development of targeted therapies
- Development of more effective and safer therapies
- Psychosocial research including supportive measures for people with lung cancer and their families
- Quality of care and outcomes research for the improvement of healthcare standards and overall patient outcomes
LCRF Pilot Grants provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators (within ten years of faculty appointment). For full details, please refer to the request for proposals on the LCRF Pilot Grant Program award page.
With support from the Stavros S. Niarchos Foundation for Charity in memory of Kathryn Louloudis, LCRF will fund two research projects in 2019 with a focus on overcoming disparities in lung cancer. These grants will provide $150,000 over a period of two years to investigators of any career level. For complete details, please refer to the request for proposals and full details on the award page.
Pfizer-LCRF Competitive Research Grant
The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to support several research projects focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies. This collaborative funding mechanism was designed to support innovative health services research proposals that leverage multidisciplinary approaches to improve the management of targeted therapy toxicities. While the application deadline for this program has passed, additional updates and the list of grantees will be published once they are announced this fall.